ライフサイエンスコーパス: vascular change

1 use axonal injury and other forms of diffuse vascular change.

2 -714 PET, especially in diseases that induce vascular change.

3 flow and sensory afferent to the ACC-induced vascular change.

4 was graded 1 to 4 for increasing severity of vascular change.

5 administration of STI571 reversed pulmonary vascular changes.

6 ated maculopathy (ARM) is related to adverse vascular changes.

7 d renal function, with minimal effect on the vascular changes.

8 P inhibitors for 1 hour affects the diabetic vascular changes.

9 studied to document progressive intracranial vascular changes.

10 important mediator for these early and late vascular changes.

11 ivity, that is not confounded by age-related vascular changes.

12 coring system, and a reporting system of the vascular changes.

13 provided more detailed visualization of the vascular changes.

14 thogenesis of inflammatory and proliferative vascular changes.

15 ted tomography (CT) scans were evaluated for vascular changes.

16 matrix-associated, but can cause pathologic vascular changes.

17 findings in AMN, with attention to choroidal vascular changes.

18 esult of neuronal dysfunction with secondary vascular changes.

19 ung disease associated with severe pulmonary vascular changes.

20 sies were graded 0 to 4 for interstitial and vascular changes.

21 culature, and astrocytic mechanosensation of vascular changes.

22 europathogenesis were analyzed for pulmonary vascular changes.

23 amination instead of by evaluation of actual vascular changes.

24 eration (72%), optic nerve pallor (68%), and vascular changes (64%) were present.

25 However, age-related vascular changes accompany or even precede the developme

26 In conclusion, the vascular changes after anti-VEGF therapy can have a cont

27 anti-IL-6 antibodies reduced nociceptive and vascular changes after fracture and inhibited lymphadeno

28 that, in anti-VEGF-refractory murine tumors, vascular changes after VEGF ablation result in reduced d

29 nt in the diagnosis of plus disease based on vascular changes alone.

30 Hot flashes may mark adverse underlying vascular changes among midlife women.

31 Although evidence suggests adverse vascular changes among women with hot flashes, it is unk

32 the effects of AG on aging-related renal and vascular changes and AGE accumulation were studied in no

33 In established cGVHD, vascular changes and anti-CSF1R efficacy were more limit

34 therapeutics and imaging agents to sites of vascular changes and astrogliosis in diseases associated

35 Vascular changes and cysts resolved within 48 h.

36 performed after 2008, and demonstrated early vascular changes and decreased platelet counts.

37 a systems map of early primary tumor-induced vascular changes and identified LRG1 as a therapeutic ta

38 shed sterol 27-hydroxylase activity leads to vascular changes and identify Cyp27a1-/- mice as a model

39 oof of concept for understanding age-related vascular changes and imply that therapeutic targeting of

40 tion of VEGF and MIP-1 alpha, leading to the vascular changes and microglial activation necessary to

41 However, vascular changes and potential effects on neural cells b

42 Age-associated vascular changes and their relation to tissue aging and

43 dicator of tumor perfusion for prediction of vascular changes and therapy response.

44 ctral endoscopy to reveal disease-associated vascular changes and to provide high-contrast delineatio

45 igate the effect of actual delivered dose on vascular changes and to test the appropriateness of the

46 Although vascular changes and transplant vasculopathy have been d

47 We monitored cell infiltration, vascular changes and tumor progression during inflammati

48 risk factor for both large and small vessel vascular changes, and conversely other vascular risk fac

49 athogenesis of early lesions of scleroderma, vascular changes, and fibrosis and perhaps lead us towar

50 be expanded to include torpedo maculopathy, vascular changes, and hemorrhagic retinopathy.

51 re development of nociceptive sensitization, vascular changes, and IgM immune complex deposition in t

52 ogic abnormalities, including cytoid bodies, vascular changes, and retinal edema, with minimal or no

53 ood, but it is suspected that the associated vascular changes are a result of anti-HLA Ab-mediated in

54 Lastly, we confirm that vascular changes are also observed in the human postmort

55 -pregnant individuals with diabetes, similar vascular changes are attributed to disruptions in endoth

56 These vascular changes are driven by the immune response to th

57 These vascular changes are due to tracing, as opposed to probl

58 -retinal barrier (BRB) breakdown and related vascular changes are implicated in several ocular diseas

59 These data support the concept that early vascular changes are involved in the pathogenesis of OAG

60 lecular components underlying these dramatic vascular changes are not well characterized.

61 However, the mechanisms producing these vascular changes are not well defined.

62 ic hernia (CDH), where the typical pulmonary vascular changes are present before birth and are accomp

63 In the neonatal stage, inflammation and vascular changes are reversible and may define an import

64 ologic studies have identified apoptosis and vascular changes as significant novel findings in human

65 thrombospondin-1 KO background reversed the vascular changes as well as the delayed catagen exhibite

66 that this pathway underlies both matrix and vascular changes associated with chronic liver disease.

67 Cs and LECs and thereby regulates matrix and vascular changes associated with chronic liver injury.

68 ithfully replicates many of the hallmarks of vascular changes associated with human retinopathy, thus

69 in activation of the immune system and cause vascular changes associated with PAH.

70 cal or pathological processes, including the vascular changes associated with sepsis.

71 ting its potential role in assessing retinal vascular changes associated with the disease.

72 Angiogenic signaling studies assessed vascular changes attributable to dysregulated HIF expres

73 types, pathways, and molecules that control vascular changes before and after ischemia may result in

74 osphamide improves Fli1 deficiency-dependent vascular changes by normalizing the expression of angiog

75 Cardiac oxidation, independently of vascular changes, can lead to uncoupled cardiac NOS and

76 de the established clinical and morphometric vascular changes caused by DM and represent a paradigm s

77 utic targets for intervention in progressive vascular changes common to cerebrovascular disease and A

78 plaques, neovascular membranes, and ectatic vascular changes commonly caused characteristic changes

79 fferential epigenetic markers and neuro-glio-vascular changes compared with nondiabetic mice.

80 Vascular changes consisted of myointimal thickening with

81 HIV have evidence of CVD risk and structural vascular changes despite viral suppression.

82 HIV have evidence of CVD risk and structural vascular changes despite viral suppression.

83 iopsies revealed that tertiary follicles and vascular changes developed in the absence of acute skin

84 ity to noninvasively detect temporal retinal vascular changes during diabetes could lead to identific

85 Detecting early retinal vascular changes during diabetes is not well documented,

86 ciated myeloid cells (TAMs) corresponding to vascular changes during GBM progression.

87 cate crosstalk between the immune system and vascular changes during ocular neovascularization format

88 nosed clinically by directly viewing retinal vascular changes during ophthalmoscopy or through fundus

89 urpose of this study was to map and quantify vascular changes during progression of DR by VESsel GENe

90 s of psoriasis, including the characteristic vascular changes, epidermal alterations, and inflammator

91 Our study describes a spectrum of vascular changes evidenced by widefield FA in pediatric

92 Choroidal vascular changes have also been noted in AMD.

93 ational modeling, we showed that these early vascular changes impaired retinal blood flow and oxygen

94 Intergrader agreement of plus-like vascular change in ROP using the P score is high.

95 be helpful in understanding dynamic retinal vascular changes in a number of common ocular diseases,

96 e noninvasive semiquantitative evaluation of vascular changes in a streptozotocin (STZ)-induced mouse

97 n DR, there is limited knowledge about these vascular changes in AA subjects.

98 Vascular changes in AD have been typically attributed to

99 In this study, we evaluated metabolic and vascular changes in AGER1 transgenic mice (AGER1-tg) sub

100 Histopathological vascular changes in all forms of PAH are qualitatively s

101 However, there were vascular changes in allografts from GN-treated mice, inc

102 r contractility, potentially contributing to vascular changes in Alzheimer's disease.

103 Such vascular changes in astronauts could compromise the main

104 n prevent and reverse these diabetic retinal vascular changes in both new and established diabetes.

105 s that distinct molecular mechanisms underly vascular changes in CMD and non-CMD involvement in SLE.

106 Both developmental hypoxia and NAC promoted vascular changes in CTH DNA and NOS3 methylation pattern

107 5LO pathway is important for mediating early vascular changes in diabetes.

108 We hypothesized that vascular changes in early acute respiratory distress syn

109 hed to identify studies that reported retina vascular changes in eyes with COVID-19.

110 ms allow for objective assessment of retinal vascular changes in eyes with DR that are correlated to

111 eJ were utilized to quantify various retinal vascular changes in fundus images.

112 ional magnetic resonance imaging to evaluate vascular changes in HCC after sunitinib treatment.

113 fic drug-induced side effects in relation to vascular changes in healthy tissues.

114 In contrast, vascular changes in isografts of hypertensive hosts were

115 he patients in this study, important retinal vascular changes in MacTel 2 occur in the deep capillary

116 RATIONALE: Early vascular changes in metabolic disease that precipitate t

117 Although the mediators responsible for these vascular changes in mice have not been identified, VEGF-

118 s study, therefore, was to analyse lymphatic vascular changes in obese mice and to determine whether

119 The present study demonstrates consistent vascular changes in pediatric patients with XLRS using w

120 gly suggest consumption of an HFD results in vascular changes in placenta reflected by alterations in

121 quantitative PCR were used to assess retinal vascular changes in relation to apoptosis, and expressio

122 ic magnetic resonance (MR) imaging to depict vascular changes in response to cyclooxygenase-2 (COX-2)

123 ture could underlie attenuation of pulmonary vascular changes in response to elevated pressure, as we

124 matory mediators, and local inflammatory and vascular changes in response to subcutaneous injection o

125 on the temporal dynamics of parenchymal and vascular changes in salivary glands following RT.

126 , we updated the guidance on neuroimaging of vascular changes in studies of ageing and neurodegenerat

127 OCTA showed retinal vascular changes in subjects fully recovered from COVID-

128 d flow (CBF), and ICP, as well as to mechano-vascular changes in the brain, which are determining par

129 provide early insight into pathology-driven vascular changes in the cord, which may precede and pred

130 to maternal high fat diets produces systemic vascular changes in the offspring.

131 stational hypertensive disorders may lead to vascular changes in the offspring.

132 in rat granulation tissue and corresponding vascular changes in the retina, sciatic nerve, and aorta

133 the major causes of blindness caused by neo-vascular changes in the retina.

134 function and prevents neurodegeneration and vascular changes in the retinas of streptozotocin (STZ)-

135 e current study, we investigated the retinal vascular changes in these animals.

136 The character of coronary vascular changes in transplanted hearts was distinctly a

137 g novel therapeutics expected to cause acute vascular changes in tumors.

138 ide detailed visualization of structural and vascular changes in XLRS and may be helpful for monitori

139 Vascular changes included progressive subendothelial hya

140 ina3n but not SOCS3 gene expression, whereas vascular changes including angiogenesis and blood-brain

141 iography images were reviewed for peripheral vascular changes including capillary dropout, late-phase

142 the best technique for measuring CNV and the vascular changes induced by anti-VEGF-A monoclonal antib

143 this combined blockade reversed normal organ vascular changes induced by Dll4 blockade alone.

144 gelatinases in particular reverse the renal vascular changes induced by pregnancy or relaxin adminis

145 re the role of nitric oxide in mediating the vascular changes induced by VEGF.

146 duced choroidal neovascularization (CNV) and vascular changes induced on CNV by an anti-VEGF-A monocl

147 Here, we consider whether vascular changes instead play a central role in disease

148 Recognizing these peripheral vascular changes is clinically important, as emphasizing

149 ut the pathogenesis of these As(III)-induced vascular changes is unknown.

150 holds promise for better imaging of retinal vascular changes, it does not reveal the key feature of

151 of fibrosis leads to vast architectural and vascular changes known as "liver cirrhosis." The signals

152 ution of portal myofibroblasts (PMFs) to the vascular changes leading to cirrhosis.

153 The pathological vascular changes led to major disruption of inner retina

154 Pathological vascular changes may also include less well characterize

155 Alzheimer pathology and stroke through which vascular changes may influence dementia risk.

156 oning and cognition, with an emphasis on how vascular changes may mediate this disorder.

157 direct allograft infection, suggesting that vascular changes may not be limited to the allograft.

158 r imaging suggest these patterns of coronary vascular changes may precede overt cardiac allograft vas

159 These vascular changes may represent a previously unrecognized

160 Vascular changes occur early in the development of obstr

161 Early vascular changes occur in the absence of vEVTs, suggesti

162 c dissection of the hormonal, metabolic, and vascular changes occurring in such women during pregnanc

163 t plus-like retinopathy of prematurity (ROP) vascular changes occurs along a spectrum.

164 ade may attenuate the cerebral and pulmonary vascular changes of IH while augmenting cerebral angioge

165 le of angiopoietins and the Tie2 receptor in vascular changes of psoriasis.

166 nucleotidohydrolase induced hemodynamic and vascular changes of pulmonary hypertension in rats (n=8)

167 niques that can more precisely visualize the vascular changes of the whole joint can further enhance

168 CT-A technology, getting deeper insight into vascular changes of this disease.

169 the potential impact of these anatomical and vascular changes on intraocular pressure (IOP) elevation

170 ffort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).

171 Standards for Reporting Vascular Changes on Neuroimaging 1 (STRIVE-1) categorise

172 s of SVD (as per the Standards for Reporting Vascular Changes on Neuroimaging [STRIVE] guidelines) an

173 form of pulmonary hypertension in which the vascular changes originate in the small pulmonary veins

174 Time-course experiments revealed that vascular changes preceded node transformation.

175 Because these metabolic and vascular changes predispose to atherosclerosis, monitori

176 ed intensity despite immunosuppression; some vascular changes progressed, while others, such as non-p

177 to moderate myocardial fibrosis, and various vascular changes ranging from focal intimal thickening t

178 basis of the migraine attack with secondary vascular changes, reconciling previous theories into a n

179 , but the time course and development of any vascular changes remain largely unexplored.

180 The molecular mechanisms of these vascular changes remain to be determined.

181 in these dogs, but the pathogenesis of this vascular change remains unknown.

182 tive effect of this compound, MEM can reduce vascular changes seen in diabetic retinas.

183 chidonic acid and that it contributes to the vascular changes seen in this model.

184 These vascular changes should alert healthcare practitioners t

185 containing 30% galactose experience retinal vascular changes similar to those in human diabetic reti

186 cate that hyperhexosemia can trigger retinal vascular changes similar to those seen in human DR inclu

187 shaped macula was likely caused by choroidal vascular changes, similar to central serous chorioretino

188 xed/decreased FAF (38%) and/or visibility of vascular changes such as blunted vessels or ectatic capi

189 The pattern of pulmonary vascular changes suggests concurrent embolic disease and

190 medium-size collaterals representing a major vascular change that contributed to the restoration of v

191 sufficient to protect against the structural vascular changes that accompany hypertension in the sett

192 targets that regulate liver fibrosis and the vascular changes that accompany it and may have broad im

193 al step in liver fibrosis and the sinusoidal vascular changes that accompany this process.

194 iated with adverse structural and functional vascular changes that are most pronounced in children ex

195 e of CsA-treated rats may be involved in the vascular changes that are seen in this model.

196 ct of PAI-1 on intimal hyperplasia and other vascular changes that develop after arterial injury in a

197 n and renin in the kidney may underlie renal vascular changes that develop in diabetes.

198 ading depression is associated with profound vascular changes that may be a significant factor in the

199 mine release and granulocyte activity in the vascular changes that precede the onset of necrotic lesi

200 dothelial cells (ECs) and nonlytically cause vascular changes that result in hemorrhagic fever with r

201 plays a role in the chronic hypoxia-induced vascular changes that underlie pulmonary hypertension.

202 phoblast-specific transgene caused placental vascular changes that were consistent with excess VEGF a

203 mage might partly originate from HIV-induced vascular changes, the timing suggests that myelin and/or

204 microvascular adhesion leads to MC-mediated vascular changes to culminate in septic shock and septic

205 e in patients with AMD by evaluating dynamic vascular changes using live ocular imaging following tre

206 ffects of aminoguanidine on diabetes-induced vascular changes versus parameters of nonenzymatic glyca

207 Associated with these vascular changes was increased elastin content in Adipo-

208 and correlation between OSAS risk score and vascular changes were calculated.

209 These vascular changes were independent of islet size and were

210 ryos with a vasoconstrictor, indicating that vascular changes were not a factor.

211 The vascular changes were not congophilic.

212 Vascular changes were not noted in gray matter 3 mm dist

213 No significant vascular changes were observed in isografts (mean medial

214 quantitative analyses of the infiltrates and vascular changes were performed.

215 owed for 6 months, killed, and rejection and vascular changes were scored blinded to the group.

216 A consistent set of retinal vascular changes were seen in the eyes with MacTel 2.

217 These vascular changes were suppressed by the administration o

218 Unanimously, it was determined that the vascular changes were to be included in the first revisi

219 development of obesity-induced metabolic and vascular changes, which is independent of its known func

220 ressed--as well as Muller glia and secondary vascular changes, which were associated at later times w

221 ough optical coherence tomography (OCT), and vascular change with Isolectin B4 (IB4) postmortem stain

222 The vascular changes, with the exception of PNAd, appear to

223 tion between examiners, and documentation of vascular change without fundus imaging.